Gilbert's syndrome
Board exam relevance: in 1 of more than 100 exam reports · rank 181- Synonyms
- Meulengracht disease, Gilbert syndrome, Gilbert disease, benign hyperbilirubinemia, mild jaundice, UGT1A1
- Specialty
- Internal medicine · Liver & biliary tract
- Last updated
- 10/2026 · Dr. Pascal Bafteh
Contents
Definition
Gilbert's syndrome (Meulengracht's disease) is a harmless, presumably lifelong metabolic variant in which the only significant abnormality is a mild, asymptomatic rise in unconjugated (indirect) bilirubin. The liver is otherwise healthy. The syndrome belongs to the inherited unconjugated hyperbilirubinaemias, which also include the rare, more severe Crigler-Najjar syndrome.
Occurrence & epidemiology
Gilbert's syndrome affects about 3–10% of the population. It is usually discovered incidentally in young adults, either through mild jaundice or through a raised bilirubin level on routine testing.
Aetiopathogenesis
The cause is mutations in the UGT1A1 gene, which encodes the enzyme UDP-glucuronyltransferase. This enzyme conjugates bilirubin with glucuronic acid, making it water-soluble and excretable in bile. In Gilbert's syndrome, enzyme activity is reduced, but not as severely as in Crigler-Najjar syndrome type II. Depending on the mutation, inheritance is autosomal dominant or autosomal recessive.
In addition, uptake of bilirubin into the liver cell is often impaired, and red cell breakdown is slightly accelerated, without causing anemia. Fasting, infections and other stresses cause bilirubin to rise.
Clinical features
Most affected people have no symptoms. At most, there is a mild, fluctuating jaundice, mainly of the sclerae, which becomes more pronounced with fasting, infections, physical exertion or stress. Liver disease does not develop; liver histology is normal. However, the finding can be mistaken for chronic hepatitis or other liver diseases.
Diagnosis
- Bilirubin: mildly raised, usually fluctuating between 2 and 5 mg/dL, predominantly unconjugated (indirect); rises with fasting
- Other liver values normal: aminotransferases, alkaline phosphatase and GGT are unremarkable
- Urine: no bilirubin in the urine, because unconjugated bilirubin is not excreted by the kidneys
- Exclusion of hemolysis: no anemia and no increased reticulocytes
- Molecular genetics: detection of a UGT1A1 variant can confirm the diagnosis but is usually not necessary
Treatment principles
- No treatment is required, as the raised bilirubin is harmless and does not affect life expectancy.
- Important points are explaining the benign nature of the condition and avoiding unnecessary investigations.
- Because glucuronidation is reduced, the toxicity of certain drugs, particularly some cytotoxic agents, may be increased, which is taken into account when planning treatment.
Specific treatment regimens with drugs and doses are covered in the InnereFuchs app.
Keep learning in the app
Further reading (open access)
Cross-references
More topics: Liver & biliary tract
- Liver cirrhosis
- Primary biliary cholangitis (PBC)
- Autoimmune hepatitis
- Esophageal varices and portal hypertension
- Wilson's disease
- Primary sclerosing cholangitis (PSC)
- Spontaneous bacterial peritonitis (SBP)
- Steatotic liver disease (fatty liver, MASLD)
- Acute liver failure
- Alcoholic hepatitis
- Ascites
- Benign liver tumors (hemangioma, FNH, adenoma)
Keep learning
Keep learning with flashcards, exam questions and spot diagnoses in the InnereFuchs app – free, in your browser or as an app.
Related pages: Liver cirrhosis · Primary biliary cholangitis (PBC) · Autoimmune hepatitis
Note: Learning content for medical education – not a treatment recommendation and no substitute for diagnosis or treatment decisions in individual cases. Treatment and management are deliberately not covered on this page.